vs
Side-by-side financial comparison of Cambium Networks Corp (CMBM) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($57.3M vs $40.3M, roughly 1.4× Cambium Networks Corp). Cambium Networks Corp runs the higher net margin — -17.9% vs -83.0%, a 65.0% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs -23.2%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs -27.2%).
Cambium Networks Corporation is an American manufacturer of wireless telecommunications equipment, including Enterprise WiFi, Network switch, Internet of Things, and fixed wireless broadband and Wi-Fi for enterprises products for Internet access. Publicly traded on the NASDAQ stock exchange, it spun out of Motorola in October 2011.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
CMBM vs RYTM — Head-to-Head
Income Statement — Q4 FY2024 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $40.3M | $57.3M |
| Net Profit | $-7.2M | $-47.5M |
| Gross Margin | 36.6% | 91.6% |
| Operating Margin | -28.4% | -82.2% |
| Net Margin | -17.9% | -83.0% |
| Revenue YoY | -23.2% | 36.9% |
| Net Profit YoY | 71.0% | -9.6% |
| EPS (diluted) | $-0.26 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $57.3M | ||
| Q3 25 | — | $51.3M | ||
| Q2 25 | — | $48.5M | ||
| Q1 25 | — | $32.7M | ||
| Q4 24 | $40.3M | $41.8M | ||
| Q3 24 | $44.7M | $33.3M | ||
| Q2 24 | $45.2M | $29.1M | ||
| Q1 24 | $47.1M | $26.0M |
| Q4 25 | — | $-47.5M | ||
| Q3 25 | — | $-52.9M | ||
| Q2 25 | — | $-46.6M | ||
| Q1 25 | — | $-49.5M | ||
| Q4 24 | $-7.2M | $-43.3M | ||
| Q3 24 | $-34.5M | $-43.6M | ||
| Q2 24 | $-14.2M | $-32.3M | ||
| Q1 24 | $-18.4M | $-141.4M |
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | 36.6% | 90.9% | ||
| Q3 24 | 43.6% | 88.5% | ||
| Q2 24 | 32.5% | 89.9% | ||
| Q1 24 | 29.8% | 89.2% |
| Q4 25 | — | -82.2% | ||
| Q3 25 | — | -102.6% | ||
| Q2 25 | — | -93.4% | ||
| Q1 25 | — | -143.7% | ||
| Q4 24 | -28.4% | -98.6% | ||
| Q3 24 | -69.6% | -132.0% | ||
| Q2 24 | -27.2% | -139.2% | ||
| Q1 24 | -33.1% | -538.7% |
| Q4 25 | — | -83.0% | ||
| Q3 25 | — | -103.1% | ||
| Q2 25 | — | -96.1% | ||
| Q1 25 | — | -151.4% | ||
| Q4 24 | -17.9% | -103.6% | ||
| Q3 24 | -77.3% | -131.2% | ||
| Q2 24 | -31.5% | -110.9% | ||
| Q1 24 | -39.2% | -544.4% |
| Q4 25 | — | $-0.73 | ||
| Q3 25 | — | $-0.82 | ||
| Q2 25 | — | $-0.75 | ||
| Q1 25 | — | $-0.81 | ||
| Q4 24 | $-0.26 | $-0.71 | ||
| Q3 24 | $-1.22 | $-0.73 | ||
| Q2 24 | $-0.51 | $-0.55 | ||
| Q1 24 | $-0.66 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $388.9M |
| Total DebtLower is stronger | $67.6M | — |
| Stockholders' EquityBook value | $-3.2M | $139.1M |
| Total Assets | $173.7M | $480.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $388.9M | ||
| Q3 25 | — | $416.1M | ||
| Q2 25 | — | $291.0M | ||
| Q1 25 | — | $314.5M | ||
| Q4 24 | — | $320.6M | ||
| Q3 24 | — | $298.4M | ||
| Q2 24 | — | $319.1M | ||
| Q1 24 | — | $201.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $67.6M | — | ||
| Q3 24 | $67.6M | — | ||
| Q2 24 | $68.9M | — | ||
| Q1 24 | $63.8M | — |
| Q4 25 | — | $139.1M | ||
| Q3 25 | — | $148.8M | ||
| Q2 25 | — | $-11.9M | ||
| Q1 25 | — | $18.9M | ||
| Q4 24 | $-3.2M | $21.7M | ||
| Q3 24 | $1.9M | $11.2M | ||
| Q2 24 | $34.1M | $39.3M | ||
| Q1 24 | $45.0M | $61.6M |
| Q4 25 | — | $480.2M | ||
| Q3 25 | — | $506.9M | ||
| Q2 25 | — | $372.7M | ||
| Q1 25 | — | $386.7M | ||
| Q4 24 | $173.7M | $392.3M | ||
| Q3 24 | $194.3M | $363.6M | ||
| Q2 24 | $221.1M | $381.8M | ||
| Q1 24 | $219.8M | $258.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 36.12× | — | ||
| Q2 24 | 2.02× | — | ||
| Q1 24 | 1.42× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.4M | $-25.4M |
| Free Cash FlowOCF − Capex | $-10.8M | — |
| FCF MarginFCF / Revenue | -26.8% | — |
| Capex IntensityCapex / Revenue | 1.1% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-21.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-25.4M | ||
| Q3 25 | — | $-26.6M | ||
| Q2 25 | — | $-23.3M | ||
| Q1 25 | — | $-40.4M | ||
| Q4 24 | $-10.4M | $-18.8M | ||
| Q3 24 | $8.9M | $-25.2M | ||
| Q2 24 | $2.4M | $-29.1M | ||
| Q1 24 | $-15.9M | $-40.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-10.8M | — | ||
| Q3 24 | $6.8M | — | ||
| Q2 24 | $87.0K | — | ||
| Q1 24 | $-17.4M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -26.8% | — | ||
| Q3 24 | 15.2% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | -37.0% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.1% | — | ||
| Q3 24 | 4.8% | — | ||
| Q2 24 | 5.1% | — | ||
| Q1 24 | 3.3% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CMBM
| Enterprise | $16.6M | 41% |
| Point To Multi Point | $16.4M | 41% |
| Other | $5.8M | 14% |
RYTM
Segment breakdown not available.
